Countless factors, from family and environment to genes and biology, influence a child’s growth and development. Scientists in the NICHD’s Section on Child and Family Research study how these factors affect the physical, mental, and social development of growing children, along with their health and well-being.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
NIH awards $35 Million for Centers for Collaborative Research in Fragile X
The National Institutes of Health is making funding awards of $35 million over the next five years to support the Centers for Collaborative Research in Fragile X program. Investigators at these centers will seek to better understand Fragile X-associated disorders and work toward developing effective treatments.
Encouraging Healthy Child Development with Birth to 5: Watch Me Thrive!
A recent survey shows that one in four young children (ages birth to 5) are at moderate to high risk for developmental, behavioral, or social delays.1 To raise awareness of these risks and promote early screening, the NICHD has joined the Administration for Children and Families and a number of other federal partners in launching Birth to 5: Watch Me Thrive!
Common gene variants account for most genetic risk for autism
Most of the genetic risk for autism comes from versions of genes that are common in the population rather than from rare variants or spontaneous glitches, researchers funded by the National Institutes of Health have found. Heritability also outweighed other risk factors in this largest study of its kind to date.
March is Trisomy Awareness Month: Time to Get "DS Connected"
During Trisomy Awareness Month in March, the NICHD joins other organizations to raise awareness about trisomy conditions and the challenges they can pose to individuals and families.
Public Comment: DRAFT NIH Research Plan on Down Syndrome 2014
The NIH Down Syndrome Working Group, formed in 2006 and led by the NICHD, aims to coordinate ongoing and new research related to Down syndrome across the NIH.
Picture This: NICHD Support for Neuroscience Research
At the annual meeting of the Society for Neuroscience , held in San Diego, California, from November 9–13, more than 30,000 neuroscientists from around the world will share their latest research results and learn about new advances and opportunities in the field.
NIH researchers identify candidate drug to treat Batten disease
Researchers at the National Institutes of Health have identified a potential new drug that could help in the treatment of a form of Batten disease, a fatal childhood disorder. The researchers tested the drug in mice with the disease and found that it slowed the loss of coordination seen in the disorder, and extended the animals’ life span.
September Is Newborn Screening Awareness Month
The NICHD has played a key role in the newborn screening activities and accomplishments of the last 5 decades and continues to lead and fund research activities related to newborn screening. As we mark the 50th anniversary of the dawn of the newborn screening era, the NICHD highlights some of its newborn screening research and accomplishments.
NIH Launches Down Syndrome Registry
Understanding Down syndrome—its mechanisms, its effects on overall health, and ways to minimize its symptoms—has been an important part of the NICHD mission since it was established. The Institute is launching the DS-Connect®: The Down Syndrome Registry in an effort to create a centralized, secure national resource for storing and sharing health information about Down syndrome.
NIH launches first national Down syndrome registry
The National Institutes of Health has launched DS-Connect, a Web-based health registry that will serve as a national health resource for people with Down syndrome and their families, researchers, and health care providers.
NIH program explores the use of genomic sequencing in newborn healthcare
Can sequencing of newborns’ genomes provide useful medical information beyond what current newborn screening already provides? Pilot projects to examine this important question are being funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Human Genome Research Institute (NHGRI), both parts of the National Institutes of Health.
Division of Epidemiology, Statistics, and Prevention Research 2012 Annual Report
The Division’s 2012 Annual Report highlights the extensive and comprehensive work of DESPR investigators and researchers.
Delay in shifting gaze linked to early brain development in autism
At 7 months of age, children who are later diagnosed with autism take a split second longer to shift their gaze during a task measuring eye movements and visual attention than do typically developing infants of the same age, according to researchers supported by the National Institutes of Health.
March Is Trisomy Awareness Month
During Trisomy Awareness Month in March, the NICHD joins other agencies and organizations in raising awareness about trisomy conditions and the challenges they may pose to individuals and families.
NIH clinical trial begins for treatment of rare, fatal neurological disorder
A clinical trial to evaluate a drug candidate called cyclodextrin as a possible treatment for Niemann-Pick disease type C1 (NPC), a rare and fatal genetic disease, will start on Wednesday, researchers announced today.
A Promising New Therapy for a Childhood Coordination Disorder
Researchers at Indiana University recently tested a three-dimensional computerized device to help train children with DCD to perform manual actions.
Scientific Vision: The Next Decade
On December 5, 2012, the NICHD released the Scientific Vision: The Next Decade, the culmination of a collaborative process that began in 2011 to identify the most promising scientific opportunities for the Institute and the research community to pursue over the next decade. The Vision statement was made available during the NICHD’s 50th anniversary colloquium.
NICHD reorganizes extramural program
Alan Guttmacher, M.D., Director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) announced a number of changes to streamline the institute’s organizational structure and accelerate the exchange of scientific ideas.
NICHD vision statement now available online
A document charting a research course for the many collaborators who share an interest in promoting the science concerning human development through the life span, child health, women's health, and rehabilitation research is now available online.